STAAR Surgical

STAAR® Surgical Company, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or “ICL.” A lens used to replace the natural lens after cataract surgery is called an intraocular lens or “IOL.” Over 500,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: STAAR has approximately 300 full time employees and markets lenses in over 70 countries. Headquartered in Monrovia, CA, conducts operations in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA.
Monrovia, US
Size (employees)
336 (est)-6%
STAAR Surgical was founded in 1982 and is headquartered in Monrovia, US

STAAR Surgical Office Locations

STAAR Surgical has offices in Monrovia and Nidau
Monrovia, US (HQ)
1911 Walker Ave
Nidau, CH
104 Hauptstrasse

STAAR Surgical Metrics

STAAR Surgical Financial Metrics

Revenue (2016)

$82.4 m

Revenue growth (2015-16), %


Gross profit

$58.4 m

Gross profit margin (2016), %


Net income (2016)

($12.1 m)

Market capitalization (28-Apr-2017)

$423.8 m

Closing share price (28-Apr-2017)


Cash (30-Dec-2016)

$14 m
STAAR Surgical's current market capitalization is $423.8 m.
STAAR Surgical's revenue was reported to be $82.4 m in FY, 2016 which is a 7% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016


$72.2 m$75 m$77.1 m$82.4 m

Revenue growth, %


Cost of goods sold

$21.9 m$26.2 m$24.4 m$24.1 m

Gross profit

$50.3 m$48.8 m$52.7 m$58.4 m

Gross profit Margin, %



$700 k($8 m)($5.3 m)($12.7 m)

EBIT margin, %


Interest income

$59 k$51 k$50 k$3 k

Net Income

$398 k($8.4 m)($6.5 m)($12.1 m)
FY, 2013FY, 2014FY, 2015FY, 2016


$23 m$13 m$13.4 m$14 m

Accounts Receivable


Current Assets

$50.1 m$44.9 m$49.1 m$49.9 m


$7.4 m$10.1 m$10.1 m$11.8 m


$1.8 m$1.8 m$1.8 m$1.8 m

Total Assets

$61.9 m$58.9 m$63 m$65.4 m

Accounts Payable

$6.3 m$6.6 m$6.7 m$8.3 m

Current Liabilities

$18.4 m$16.4 m$17.9 m$21.1 m

Additional Paid-in Capital

$170.2 m$178.2 m$187 m$197.7 m

Retained Earnings

($132.1 m)($140.4 m)($147 m)($159.1 m)

Total Equity

$38.8 m$37.9 m

Financial Leverage

1.6 x1.7 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$398 k($8.4 m)($6.5 m)($12.1 m)

Depreciation and Amortization

$1.7 m$2.1 m$2.2 m$2.7 m

Accounts Receivable

($771 k)


($1.6 m)

Accounts Payable

$367 k$972 k$14 k$1 m

Cash From Operating Activities

$3.4 m($9.9 m)$389 k$1 m

Purchases of PP&E

($3.4 m)($4.1 m)($2 m)($3.2 m)

Cash From Investing Activities

($3.4 m)($4.1 m)($2 m)($3.2 m)

Cash From Financing Activities

$2.4 m$2.5 m$4.6 m$3 m

STAAR Surgical Market Value History

STAAR Surgical Online Presence

STAAR Surgical Company Life

You may also be interested in